Place of sodium-glucose cotransporter-2 inhibitors in East Asian subjects with type 2 diabetes mellitus: Insights into the management of Asian phenotype-Reference-Cited by-同舟云学术

Place of sodium-glucose cotransporter-2 inhibitors in East Asian subjects with type 2 diabetes mellitus: Insights into the management of Asian phenotype

Published:2017-02 Issue:2 Volume:31 Page:494-503
ISSN:1056-8727
Container-title:Journal of Diabetes and its Complications
language:en
Short-container-title:Journal of Diabetes and its Complications

Author:

Lim Lee Ling,Tan Alexander Tong Boon,Moses Kevin,Rajadhyaksha Viraj,Chan Siew Pheng

Funder

AstraZeneca, Malaysia

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference83 articles.

1. Achievement of goals in U.S. diabetes care, 1999–2010;Ali;The New England Journal of Medicine,2013

2. Efficacy and safety of dapagliflozin in addition to insulin therapy in Japanese patients with type 2 diabetes: Results of the interim analysis of 16-week double-blind treatment period;Araki;Journal of Diabetes Investigation,2016

3. Long-term treatment with empagliflozin as add-on to oral antidiabetes therapy in Japanese patients with type 2 diabetes mellitus;Araki;Diabetes, Obesity & Metabolism,2015

4. Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: A randomized, double-blind, placebo-controlled 102-week trial;Bailey;BMC Medicine,2013

5. Efficacy and safety of dapagliflozin monotherapy in people with type 2 diabetes: A randomized double-blind placebo-controlled 102-week trial;Bailey;Diabetic Medicine,2015

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the Nexus: Lifestyle Factors and Pancreatic Dysfunction;J PANCREAS;2024

2. Predictors of weight reduction effectiveness of SGLT2 inhibitors in diabetes mellitus type 2 patients;Frontiers in Endocrinology;2024-01-24

3. Epidemiology of Diabetes and Atherosclerotic Cardiovascular Disease Among Asian American Adults: Implications, Management, and Future Directions: A Scientific Statement From the American Heart Association;Circulation;2023-07-04

4. Does race/ethnicity influence the impact of new glucose-lowering agents on cardiovascular outcomes? a comparison between Asian versus White patients;Annals of Translational Medicine;2022-12

5. Safety of sodium–glucose c otransporter 2 inhibitors in Asian type 2 diabetes populations;Journal of Diabetes Investigation;2022-10-19